TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 78 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $434,759 | -7.9% | 11,529 | -7.4% | 0.00% | 0.0% |
Q2 2023 | $472,039 | +99.6% | 12,445 | +28.0% | 0.00% | – |
Q1 2023 | $236,512 | -16.3% | 9,725 | 0.0% | 0.00% | – |
Q4 2022 | $282,414 | -3.3% | 9,725 | 0.0% | 0.00% | – |
Q3 2022 | $292,000 | -19.8% | 9,725 | -3.4% | 0.00% | -100.0% |
Q2 2022 | $364,000 | -16.3% | 10,066 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $435,000 | -19.7% | 10,066 | -7.0% | 0.00% | 0.0% |
Q4 2021 | $542,000 | -21.3% | 10,823 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $689,000 | -0.3% | 10,823 | +12.7% | 0.00% | 0.0% |
Q2 2021 | $691,000 | -5.0% | 9,600 | -2.7% | 0.00% | 0.0% |
Q1 2021 | $727,000 | +0.4% | 9,863 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $724,000 | -21.6% | 9,863 | +20.4% | 0.00% | -50.0% |
Q3 2017 | $923,000 | +0.5% | 8,192 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $918,000 | -20.7% | 8,192 | -17.5% | 0.00% | 0.0% |
Q1 2017 | $1,157,000 | +15.8% | 9,925 | +4.6% | 0.00% | 0.0% |
Q4 2016 | $999,000 | – | 9,487 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 85,205 | $9,416,000 | 7.01% |
FORT, L.P. | 149,014 | $16,468,000 | 5.67% |
Strategic Global Advisors, LLC | 80,231 | $11,336,000 | 4.23% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 701,900 | $77,567,000 | 3.19% |
Ativo Capital Management LLC | 78,727 | $8,700,000 | 2.01% |
Analyst IMS Investment Management Services Ltd. | 31,438 | $3,474,000 | 1.47% |
Parametrica Management Ltd | 4,327 | $478,000 | 1.32% |
Freestone Capital Holdings, LLC | 89,005 | $9,836,000 | 0.90% |
RPG Investment Advisory, LLC | 19,580 | $2,163,000 | 0.68% |
MERITAGE PORTFOLIO MANAGEMENT | 38,465 | $4,251,000 | 0.47% |